volume 27, issue 3, P254-264 2006
DOI: 10.2500/aap.2006.27.2852
View full text
|
Sign up to set email alerts
|
Share

Abstract: Intranasal steroids (INSs) are recommended as first-line treatment for allergic rhinitis (AR) and a wealth of data exist supporting them as safe and effective. Our goal was to develop a consensus to help physicians choose between INSs by focusing on clinical profiles and patient preferences and providing expert advice on choosing the appropriate INS for each patient. Experts from specialties that manage patients with AR attended a roundtable meeting to discuss INS therapy. Besides comparisons with other pharma…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
8
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals